Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2004
06/17/2004US20040116432 Triazolo[4,3b]pyridazine as kinase inhibitors for treatment of cancerin mammals
06/17/2004US20040116429 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
06/17/2004US20040116426 Small molecules useful in the treatment of inflammatory disease
06/17/2004US20040116410 Diazepinones as antiviral agents
06/17/2004US20040116399 for preventing or treating coagulation disorders
06/17/2004US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
06/17/2004US20040116346 For use in therapy of anemia, as well as in other functions associated with assays for EPO-R, studying EPO and EPO-R function, purification of EPO-R
06/17/2004US20040116328 Condensed imidazole derivatives
06/17/2004US20040115724 Macrocyclic compounds and their use
06/17/2004DE10255343A1 N,N-Verbrückte, Stickstoff-Substituierte Carbacyclische Indolocarbazole als Proteinkinase-Inhibitoren N, N-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors
06/17/2004CA2508724A1 Preparation of metallotexaphyrins
06/17/2004CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use
06/17/2004CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds
06/17/2004CA2506741A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
06/17/2004CA2506546A1 Kinase modulators
06/16/2004EP1427732A1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a]pyrazol-1-ones which control inflammatory cytokines
06/16/2004EP1427731A1 Process for the preparation of highly pure triethylene diamine
06/16/2004EP1427730A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
06/16/2004EP1427728A1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES
06/16/2004EP1427727A1 Compounds which inhibit the release of inflammatory cytokines
06/16/2004EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
06/16/2004EP1427712A2 Dye-azide compounds for dual phototherapy
06/16/2004EP1427410A1 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
06/16/2004EP1339719B1 Benzimidazole derivatives, preparation and therapeutic use thereof
06/16/2004EP1315731B1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/16/2004EP1261344B1 Use of indoloquinoxalines for the treatment of multiple sklerosis
06/16/2004EP1214075B1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO
06/16/2004EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
06/16/2004EP0977725B1 New fatty acid derivatives
06/16/2004EP0817635B1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
06/16/2004CN1505632A Triazolopyrimidines
06/16/2004CN1505631A Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands
06/16/2004CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase
06/15/2004US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine
06/15/2004US6750344 Monocyclic amine scaffold bearing at least two sites of diversity, cyclized to form bicyclic amine scaffolds; 7-amino-pyrrolo(1,2-a)pyrazin-4-one compounds
06/15/2004US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
06/15/2004US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions
06/15/2004US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis
06/15/2004CA2183735C Hetero-annulated indazoles
06/10/2004WO2004048384A1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors
06/10/2004WO2004048383A1 Mixed lineage kinase modulators
06/10/2004WO2004048382A1 Quinolinyl-pyrrolopyrazoles
06/10/2004WO2004048381A2 Pyrazoloazepine compounds as pharmaceutical agents
06/10/2004WO2004048363A1 Imidazole derivative, process for producing the same, and use
06/10/2004WO2004047725A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/10/2004WO2004032845A3 R-nsaid esters and their use
06/10/2004WO2004032836A3 Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors
06/10/2004WO2004024091A3 Expanded porphyrin compositions for tumor inhibition
06/10/2004WO2004002405A3 Amino-bicyclic pyrazinones and pyridinones
06/10/2004US20040110962 Synthesis of certain triazole compounds
06/10/2004US20040110948 Novel process for the preparation of pyrazolopyrimidinones
06/10/2004US20040110944 4,7-Disubstituted indoles and methods of making
06/10/2004US20040110826 Alpha 2c-adrenoceptor antagonists comprising 1- (benzylamino)-1,2,4]triazolo[1,5-c]pyrimidine derivatives; Parkinson's disease, dyskinesias, antidepressants; hypotensive, antidiabetic agents; eating,sexual disorders
06/10/2004US20040110820 Expanded porphyrin compositions for tumor inhibition
06/10/2004US20040110802 Antibacterial benzoic acid derivatives
06/10/2004US20040110798 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders
06/10/2004US20040110797 Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
06/10/2004US20040110778 A 3,10-diaza-benzo[e]azulene, 3,8,10-triaza-benzo[e]azulene, or 1,3a,6-triaza-as-indacene derivatives, used to treat anxiety, depression, a sleep disorder, or Alzheimer's dementia.
06/10/2004US20040110773 Pyrimido compounds having antiproliferative activity
06/10/2004US20040110772 Inhibitors of nucleoside phosphorylases and nucleosidases
06/10/2004US20040110771 (R)-5-chloro-7-(3,3-dimethylbut-2-yl)amino-6-(2,4,6-trifluoro-phenyl)-1,2,4-triazolo[1,5-a]pyrimidine for example; improved activity and/or a broader activity spectrum; by a R-configured halogen-free amino radical in the 7-position
06/10/2004US20040110769 Antitumor agents for cancer treatment; 5-(3-chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo[1,5-a]quinazoline-7-methanamine with tamoxifen for example
06/10/2004US20040110764 Inhibit oncogene Ras; treating neurofibromin benign proliferative disorder; cancer (combination therapy); blindness, hepatitis infection, restenosis, polycystic kidney disease; imidazo[2,1-b]thiazole derivatives for example
06/10/2004US20040110761 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
06/10/2004US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct
06/10/2004US20040110751 6-(2-chloro-6-fluoro-phenyl)-triazolopyrimidines
06/10/2004US20040110229 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
06/10/2004US20040109890 Tablets quickly disintegrated in oral cavity
06/10/2004CA2507026A1 Imidazole derivatives, their production and use
06/10/2004CA2506799A1 Mixed lineage kinase modulators
06/10/2004CA2502200A1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors
06/10/2004CA2498566A1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/09/2004EP1426377A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines
06/09/2004EP1426375A2 Analgesic spiroindole derivatives
06/09/2004EP1426050A1 Jnk inhibitors
06/09/2004EP1425355A1 A compressed fluid formulation
06/09/2004EP1425286A1 Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of diseases
06/09/2004EP1425282A2 Process for the preparation of diketopyrrolopyrroles
06/09/2004EP1425279A2 Method for the preparation of crystalline tetrahydrobenzothiepines
06/09/2004EP1425029A1 Peptidomimetics of biologically active metallopeptides
06/09/2004EP1424942A1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
06/09/2004EP1337535B1 Benzodiazepine derivatives as gaba a receptor modulators
06/09/2004EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
06/09/2004EP1148875B1 Methods and compositions to enhance white blood cell count
06/09/2004EP1073660B1 Yellow pteridine having a hue-angle of at least 98
06/09/2004EP1027398B1 Light-emitting dendrimers and devices
06/09/2004CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists
06/09/2004CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/09/2004CN1503672A 6-substituted pyrido-pyrimidines
06/09/2004CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives
06/09/2004CN1152867C Quinazoline derivatives as medicaments
06/09/2004CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
06/08/2004US6747144 Collections of compounds
06/08/2004US6747035 Antiinflammatory agents; antiallergens
06/08/2004US6747033 N-(5-chloro-4-methyl-s-(2,4,6 -trifluorophenyl)-4h-(1,2,4)-triazolo(1,5-a)pyrimidin-7-ylidene)-n-(2,2,2 -trifluoroethyl)-amine, for example; improved activity
06/08/2004US6746989 Substituted benzoylpyrazoles as herbicides
06/08/2004US6746663 Porphyrin compounds
06/03/2004WO2004046173A1 Scaffolds useful to the synthesis of compounds with biological activity
06/03/2004WO2004046151A2 Porphyrin derivatives